Skip to main content
. 2023 Jul 6;108(12):3321–3332. doi: 10.3324/haematol.2023.283426

Figure 4.

Figure 4.

Difference in relapse by high-risk mutations in the cohort of 90 patients with next-generation sequencing data. (A) Relapse by number of high-risk mutations. (B) Relapse by EZH2, RUNX1, or SETBP1 mutations (Mut). NGS: next-generation sequencing.